Elsa Camarillo, DO
Pulmonary Disease · Orange, CANPI 1194187781
Payments from drug & device makers
Across 88 payments — averaging $120.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$5K
- Noah Medical Corporation$2K
- Steris Corporation$1K
- Pinnacle Biologics, Inc$898
- United Therapeutics Corporation$213
- Boehringer Ingelheim$208
- plus $1K from 10 others
What the payments were for
- Travel & lodging$6,33060%
- Food & beverage$4,27940%
- Gifts$90%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 46 | $4,823 |
| Noah Medical Corporation | 9 | $1,949 |
| Steris Corporation | 6 | $1,460 |
| Pinnacle Biologics, Inc | 10 | $898 |
| United Therapeutics Corporation | 2 | $213 |
| Boehringer Ingelheim | 2 | $208 |
| Pulmonx Corporation | 3 | $177 |
| Johnson & Johnson(2 entities) | 2 | $155 |
| Olympus America Inc. | 1 | $130 |
| Abiomed | 1 | $130 |
| Galvanize Therapeutics, Inc | 1 | $117 |
| Insmed, Inc. | 1 | $110 |
| AstraZeneca | 1 | $108 |
| Boston Scientific | 1 | $78 |
| Olympus Corporation Of The Americas | 1 | $44 |
| Abbott | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$3,869
- GALAXY$1,794
- TRUFREEZE$1,241
- Photofrin$630
- MONARCH$134
- Single-Use flexible Video Bronchoscope$130
- Spiration Valve System$130
- Impella$130
- ORENITRAM$123
- ALIYA SYSTEM$117
- CHARTIS CATHETER$117
- ZEPHYR DELIVERY CATHETER$117
- ZEPHYR ENDOBRONCHIAL VALVE$117
- PULMONX CHARTIS TABLET CONSOLE$117
- Arikayce$110
How this compares
$10,618 in reported general payments places this provider in the 75th percentile of 1,261 pulmonary disease providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Orange
- James PearleOrange$1.1M
- Toby MaherLos Angeles$27.6M
- David PhamWestminster$5.9M
- Andrew WachtelLos Angeles$5.9M
- Aaron WeinbergIrvine$5.1M
- Michael RothLos Angeles$4.5M
- Namita SoodSacramento$3.7M
- Edward FedermanSan Diego$3.6M
- Sanjay VadgamaSherman Oaks$3.3M
- Rajan SaggarLos Angeles$3.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.